Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1973 1
1976 2
1978 1
1979 1
1986 1
1987 1
1989 1
1990 1
1992 2
2001 1
2006 1
2007 1
2012 1
2013 1
2014 1
2015 1
2016 1
2018 1
2019 1
2020 1
2021 2
2022 1
2023 3
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.
Wells DK, van Buuren MM, Dang KK, Hubbard-Lucey VM, Sheehan KCF, Campbell KM, Lamb A, Ward JP, Sidney J, Blazquez AB, Rech AJ, Zaretsky JM, Comin-Anduix B, Ng AHC, Chour W, Yu TV, Rizvi H, Chen JM, Manning P, Steiner GM, Doan XC; Tumor Neoantigen Selection Alliance; Merghoub T, Guinney J, Kolom A, Selinsky C, Ribas A, Hellmann MD, Hacohen N, Sette A, Heath JR, Bhardwaj N, Ramsdell F, Schreiber RD, Schumacher TN, Kvistborg P, Defranoux NA. Wells DK, et al. Cell. 2020 Oct 29;183(3):818-834.e13. doi: 10.1016/j.cell.2020.09.015. Epub 2020 Oct 9. Cell. 2020. PMID: 33038342 Free PMC article.
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial.
Yarchoan M, Gane EJ, Marron TU, Perales-Linares R, Yan J, Cooch N, Shu DH, Fertig EJ, Kagohara LT, Bartha G, Northcott J, Lyle J, Rochestie S, Peters J, Connor JT, Jaffee EM, Csiki I, Weiner DB, Perales-Puchalt A, Sardesai NY. Yarchoan M, et al. Among authors: bartha g. Nat Med. 2024 Apr;30(4):1044-1053. doi: 10.1038/s41591-024-02894-y. Epub 2024 Apr 7. Nat Med. 2024. PMID: 38584166 Free PMC article. Clinical Trial.
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma.
Black JRM, Bartha G, Abbott CW, Boyle SM, Karasaki T, Li B, Chen R, Harris J, Veeriah S, Colopi M, Bakir MA, Liu WK, Lyle J, Navarro FCP, Northcott J, Pyke RM, Hill MS, Thol K, Huebner A, Bailey C, Colliver EC, Martínez-Ruiz C, Grigoriadis K, Pawlik P, Moore DA, Marinelli D, Shutkever OG, Murphy C, Sivakumar M; TRACERx consortium; Shaw JA, Hackshaw A, McGranahan N, Jamal-Hanjani M, Frankell AM, Chen RO, Swanton C. Black JRM, et al. Among authors: bartha g. Nat Med. 2025 Jan;31(1):70-76. doi: 10.1038/s41591-024-03216-y. Epub 2025 Jan 13. Nat Med. 2025. PMID: 39806071 Free PMC article.
Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction.
Black JRM, Karasaki T, Abbott CW, Li B, Veeriah S, Al Bakir M, Liu WK, Huebner A, Martínez-Ruiz C, Pawlik P, Moore DA, Marinelli D, Shutkever O, Murphy C, Liu LY, Grieco C, Grimes K, Navarro FCP, Pyke RM, Bartha G, Keough KC, Dea S, Ravi N, Lyle J, Harris J, Brown KD, Blackhall FH, Hassani F, Fennell DA, McGranahan N, Shaw JA, Abbosh C; TRACERx Consortium; Hackshaw A, Jamal-Hanjani M, Frankell AM, Boyle SM, Chen RO, Swanton C. Black JRM, et al. Among authors: bartha g. Cell. 2025 Nov 7:S0092-8674(25)01192-4. doi: 10.1016/j.cell.2025.10.020. Online ahead of print. Cell. 2025. PMID: 41205598 Free article.
Correction: Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.
Northcott J, Bartha G, Harris J, Li C, Navarro FCP, Pyke RM, Hong M, Zhang Q, Ma S, Chen TX, Lai J, Udar N, Saldivar JS, Ayash E, Anderson J, Li J, Cui T, Le T, Chow R, Velasco RJ, Mallo C, Santiago R, Bruce RC, Goodman LJ, Chen Y, Norton D, Chen RO, Lyle JM. Northcott J, et al. Among authors: bartha g. Oncotarget. 2024 Jun 20;15:407. doi: 10.18632/oncotarget.28581. Oncotarget. 2024. PMID: 38900651 Free PMC article. No abstract available.
Basecalling with LifeTrace.
Walther D, Bartha G, Morris M. Walther D, et al. Among authors: bartha g. Genome Res. 2001 May;11(5):875-88. doi: 10.1101/gr.177901. Genome Res. 2001. PMID: 11337481 Free PMC article.
Analytic validation of NeXT Dx™, a comprehensive genomic profiling assay.
Saldivar JS, Harris J, Ayash E, Hong M, Tandon P, Sinha S, Hebron PM, Houghton EE, Thorne K, Goodman LJ, Li C, Marfatia TR, Anderson J, Morra M, Lyle J, Bartha G, Chen R. Saldivar JS, et al. Among authors: bartha g. Oncotarget. 2023 Aug 30;14:789-806. doi: 10.18632/oncotarget.28490. Oncotarget. 2023. PMID: 37646774 Free PMC article.
Withdrawn: Precision Neoantigen Discovery Using Large-scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation.
Pyke RM, Mellacheruvu D, Dea S, Abbott CW, Zhang SV, Phillips NA, Harris J, Bartha G, Desai S, McClory R, West J, Snyder MP, Chen R, Boyle SM. Pyke RM, et al. Among authors: bartha g. Mol Cell Proteomics. 2021;20:100111. doi: 10.1016/j.mcpro.2021.100111. Epub 2021 Jun 12. Mol Cell Proteomics. 2021. Retraction in: Mol Cell Proteomics. 2023 Apr;22(4):100511. doi: 10.1016/j.mcpro.2023.100511. PMID: 34126241 Free PMC article. Retracted.
34 results